Illumina Inc ILMN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:41 AM EDT
395.57quote price arrow down-6.39 (-1.59%)
Volume
410,983
52 week range
260.42 - 555.77

...

Loading . . .
  • Open401.89
  • Day High402.39
  • Day Low390.52
  • Prev Close401.96
  • 52 Week High555.77
  • 52 Week High Date02/12/21
  • 52 Week Low260.42
  • 52 Week Low Date09/21/20

Key Stats

  • Market Cap57.714B
  • Shares Out145.90M
  • 10 Day Average Volume1.09M
  • Dividend-
  • Dividend Yield-
  • Beta0.95
  • YTD % Change6.38

KEY STATS

  • Open401.89
  • Day High402.39
  • Day Low390.52
  • Prev Close401.96
  • 52 Week High555.77
  • 52 Week High Date02/12/21
  • 52 Week Low260.42
  • 52 Week Low Date09/21/20
  • Market Cap57.714B
  • Shares Out145.90M
  • 10 Day Average Volume1.09M
  • Dividend-
  • Dividend Yield-
  • Beta0.95
  • YTD % Change6.38

RATIOS/PROFITABILITY

  • EPS (TTM)4.43
  • P/E (TTM)89.25
  • Fwd P/E (NTM)70.61
  • EBITDA (MRQ)767.00M
  • ROE (MRQ)14.10%
  • Revenue (MRQ)3.239B
  • Gross Margin (MRQ)68.01%
  • Net Margin (MRQ)20.25%
  • Debt To Equity (MRQ)25.22%

EVENTS

  • Earnings Date04/27/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO5:5605:56
Illumina CEO Francis deSouza on first-quarter results, outlook and more

Profile

MORE
Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations. Core Illumina's products and services serve customers in the research, clinical and applied markets, and enable the adoption of a...
Jay Flatley
Chairman
John Thompson
Chairman
Francis deSouza
President
Sam Samad
Chief Financial Officer
Address
5200 Illumina Way
San Diego, CA
92122-4616
United States

Top Peers

SYMBOLLASTCHG%CHG
MRNA
Moderna Inc
169.91+10.04+6.28%
SGEN
Seagen Inc
145.79-3.85-2.57%
REGN
Regeneron Pharmaceuticals Inc
503.00+8.36+1.69%
ALXN
Alexion Pharmaceuticals Inc
163.95+6.41+4.07%
INCY
Incyte Corp
82.03-1.17-1.41%